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ABSTRACT
Aims/Introduction: Little is known about the impact of sleep duration and late-night
snacking on glycemic control in patients with type 1 diabetes using insulin pumps. The
aim of the present study was to examine whether late-night eating habits and short sleep
duration are associated with glycemic control in continuous subcutaneous insulin infu-
sion-treated type 1 diabetic patients.
Materials and Methods: We included 148 consecutive adult type 1 diabetic subjects
using an insulin pump (100 women and 48 men). Participants completed a questionnaire
regarding sleep duration (classified as short if ≤6 h) and late-night snacking. Other sources
of information included medical records and data from blood glucose meters. Glycemic
control was assessed by glycated hemoglobin (HbA1c) levels and mean self-monitoring of
blood glucose (SMBG) readings.
Results: The mean age of patients was 26 years, mean type 1 diabetes duration was
13.4 years and mean HbA1c level was 7.2%. In a univariate regression analysis, sleep dura-
tion was a predictor of both HbA1c (b = 0.51, P = 0.01) and SMBG levels (b = 11.4,
P = 0.02). Additionally, an association was found between frequent late-night snacking
and higher SMBG readings (often snacking b = 18.1, P = 0.05), but not with increased
HbA1c levels. In the multivariate linear regression, independent predictors for HbA1c and
SMBG were sleep duration and patient age. In a univariate logistic regression, sleep dura-
tion and frequency of late-night snacking were not predictors of whether HbA1c target
levels were achieved.
Conclusions: Short sleep duration, but not late-night snacking, seems to be associated
with poorer glycemic control in type 1 diabetic patients treated with continuous subcuta-
neous insulin infusion.
INTRODUCTION
The Diabetes Control and Complications Trial (DCCT) proved
that in type 1 diabetes, intensive insulin therapy as compared
with conventional treatment improves long-term health out-
comes1. The intensive insulin therapy can be implemented
either with continuous subcutaneous insulin infusion (CSII) by
a personal pump or multiple daily injections (MDI). The use of
pump therapy has potential benefits for type 1 diabetic patients,
because it offers a customized, flexible basal and bolus dosing
to meet a patient’s individual insulin requirement. This system
of insulin delivery is not only associated with an improvement
in glycemic control, but also increased physical and psychologi-
cal well-being2–6. The enhanced lifestyle flexibility, mainly
related to sleep and mealtimes, is one of the major reasons for
choosing CSII for a growing number of type 1 diabetic
patients7,8. However, concerns have also been raised whether
greater dietary freedom associated with CSII could give a riseReceived 2 October 2014; revised 6 November 2014; accepted 27 November 2014
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to undesirable behaviors; for example, related to food consump-
tion9. One of them is late-night eating habits that might poten-
tially impair glycemic control. Eating late can be also associated
with shorter sleep duration10. Sleep is a physiological state that
constitutes the most effective form of rest. However, over the
past 100 years, the average sleep duration has shortened by
1.5 h/night11. Currently, in the USA, one in three adults sleeps
less than 6.5 h/night11,12. A meta-analysis carried out on the
general population found that short sleep duration and very
long sleep duration were associated with an increased risk of
cardiovascular disease, stroke and associated mortality13. Recent
studies have shown that might may be a U-shaped relationship
between sleep duration and glycemic control in type 2 diabe-
tes14,15. It was also reported that patients with type 1 diabetes,
as well as their families, slept for an insufficient number of
hours, according to the recommendations10.
The current study aimed to examine whether late eating hab-
its and short sleep duration are associated with glycemic con-
trol, as assessed by glycated hemoglobin (HbA1c) levels and
mean self-monitoring of blood glucose (SMBG) readings in
CSII-treated adult type 1 diabetic patients.
MATERIALS AND METHODS
The present study was carried out at the Department of Meta-
bolic Diseases, Krakow, a university referral center for diabetes
care in southeastern Poland. The study population included
148 consecutive adult type 1 diabetic patients using insulin
pumps (100 women and 48 men) who registered in 2013 and
completed a questionnaire regarding topics such as subjective
average sleep duration (classified as short sleep duration when
≤6 h and long sleep duration >6 h) and late night snacking
habits (eating after 22.00 h rarely, sometimes or often). All
invited type 1 diabetic patients completed the questionnaire;
however, two participants did not provide any information
about sleep duration. Type 1 diabetic patients less than
18 years-of-age and pregnant women were excluded from the
present study. Other sources of information about patient char-
acteristics (together with diabetic complications) included avail-
able medical records, as well as the results of biochemical tests
(HbA1c measured using the high performance liquid chroma-
tography method) and data from blood glucose meters, which
were downloaded regularly onto a computer. Glycemic control
was assessed by two parameters: HbA1c levels and mean
SMBG readings calculated from glucose meter data. Informa-
tion was also collected on subjective hypoglycemia perception
defined as the level of glucose at which the subject perceives
early symptoms of hypoglycemia. A hypoglycemic episode was
defined as an event where glucose concentration measured with
a glucose meter was 55 mg/dL or less, as defined by the Polish
Diabetes Association during the time when the study was car-
ried out16.
Tests for differences between the two groups (Student’s t-test
or Mann–Whitney U-test), uni- and multivariate linear regres-
sion analyses, as well as uni- and multivariate logistic regression
for predictors of reaching the therapeutic targets of HbA1c
<7.0% (53 mmol/mol, as recommended by the American Dia-
betes Association) and HbA1c <6.5% (48 mmol/mol, as sug-
gested by the Polish Diabetes Association) were used16. In the
present multivariate analysis, the following characteristics were
included as independent variables: sleep duration (long sleep
duration as a baseline), frequency of late night snacking
(dummy variable with rare snacking after 22.00 h as a base-
line), body mass index, age and sex. P-values <0.05 were con-
sidered significant. The v2-test or Fisher’s exact test were used
for categorical variables. Statistical analysis was carried out
using Statistica PL version 10.0 (StatSoft Inc, Tulsa, OK, USA)
and R version 3.1.1 (http://www.r-project.org/).
The study protocol was approved by the ethical committee
of the Jagiellonian University Medical College. All procedures
followed were in accordance with the ethical standards of the
responsible committee on human experimentation (institutional
and national) and the Helsinki Declaration of 1975, as revised
in 2008.
Informed consent was obtained from all patients included in
the study.
RESULTS
Clinical characteristics of the patients are summarized in
Table 1. The patients’ mean age was 26.3 – 9.0 years, mean
type 1 diabetes duration was 13.4 – 7.4 years, mean HbA1c
level was 7.2 – 1.0%, mean body mass index was
23.3 – 3.1 kg/m2, while mean night-time sleep duration was
7.2 – 1.1 h. Most participants were free from chronic diabetic
complications, as the proportion of patients with retinopathy,
neuropathy and nephropathy were 7.43% (n = 11), 7.43%
(n = 11) and 2.70% (n = 4), respectively. Short sleep duration
(26.3% of patients) as compared with long sleep duration
was associated with poorer glycemic control: HbA1c 7.6 vs
7.1%, P = 0.03; mean SMBG readings 159 vs 149 mg/dL,
P = 0.05, respectively. Patients who slept longer tended to
have more hypoglycemic episodes per 100 glucometer mea-
surements (P = 0.05). It was also investigated whether there
was a U-shaped relationship between sleep duration and gly-
cemic control (with higher HbA1c levels in patients with an
average self-reported sleep duration ≤6 h/night and ≥8 h/
night compared with those with 6–8 h/night); however, there
was no significant difference between the groups (P = 0.32).
There was no association between sleep duration and late
night snacking behavior (P = 0.33). Eating late, but not
shorter sleep duration, was more frequently found in males
treated with CSII (P = 0.01, P = 0.49, respectively). Patient
characteristics, according to sleep duration are shown in
Table 1.
When undertaking a univariate linear regression, sleep dura-
tion was found to be a predictor of both HbA1c (b = 0.51;
P = 0.01) and SMBG levels (b = 11.4; P = 0.02). Additionally,
it was found that the variable frequency of late night snacking
(dummy variable with rare snacking after 22.00 h as a baseline)
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was a predictor of SMBG (often snacking b = 18.1; P = 0.05),
but not of HbA1c levels (P > 0.09). In the multivariate linear
regression analysis, independent predictors for HbA1c were the
patient’s age (b = -0.02, P = 0.01) and sleep duration
(b = 0.51, P = 0.01). The analyzed model was significant
(P = 0.01). In the multivariate regression analysis for mean
SMBG readings, the same variables remained significant
(patient’s age [b = -0.67, P = 0.01] and sleep duration
[b = 11.5, P = 0.02]).
In the univariate logistic regression analysis, sleep duration
and frequency of late-night snacking were not predictors of
achieving HbA1c expressed therapeutic targets (<6.5%
[48 mmol/mol] or 7.0% [53 mmol/mol], respectively). In the
multivariate logistic regression analysis that included age, body
mass index and sex as independent variables, age was the only
independent predictor of both therapeutic goals (OR 1.04, 95%
confidence interval 1.00–1.09, for both analyses).
DISCUSSION
The present retrospective study is the first to assess a potential
association between sleep duration and late-night snacking with
glycemic control in type 1 diabetic patients treated with CSII.
The mean night-time sleep duration for our cohort was 7.2 h,
which is comparable with previous data from type 1 diabetic
patients17. The key finding of the present study was that
shorter sleep duration was associated with worse glycemic con-
trol after adjustment for potential confounders. One can attri-
bute this finding to the fact that a shorter sleep duration
produces insulin resistance through the increased secretion of
stress and other hormones, such as ghrelin and leptin, which
leads to neurohormonal dysregulation10,18–21. There has only
been one previous study (cross-sectional) that showed a deteri-
orating effect of chronic sleep deprivation on glycemic control
in patients with type 1 diabetes10. Interestingly, it was also
reported that type 1 diabetic patients with a long history of
the disease have poor subjective sleep quality, but no associa-
tion between individual sleep characteristics and glycemic con-
trol was found17. There have also been some studies in healthy
subjects proving that partial sleep restriction decreased glucose
tolerance and induced insulin resistance22,23. Interestingly, the
percentage of patients treated with CSII showing a potentially
“unhealthy” habit of eating late was relatively high in the pres-
ent study, although, late-night snacking was not an indepen-
dent factor influencing glycemic control. It should be also
Table 1 | Study group characteristics
Variable Whole study group Sleep ≤6 h Sleep >6 h P-value†
n (%) n (%) n (%)
Sex (male/female) 48/100 (32.4/67.6) 14/25 (35.9/64.1) 32/75 (29.9/70.1) 0.4905
Retinopathy‡ 11 (7.4) 4 (10.2) 7 (6.5) 0.4849
Neuropathy§ 11 (7.4) 1 (2.6) 10 (9.3) 0.2889
Nephropathy¶ 4 (2.7) 2 (5.1) 2 (1.9) 0.2897
Frequency of late-night snacking
(rarely/sometimes/often)
80/57/11 (54.1/38.5/7.4) 18/19/2 (46.1/48.7/5.1) 61/38/8 (57/35.5/7.5) 0.3449
Patients with HbA1c <7% 61 (44.8) 13 (36.1) 47 (47.9) 0.2215
Patients with HbA1c <6.5% 36 (26.5) 8 (22.2) 28 (28.6) 0.4624
Variable Mean SD Median Mean SD Median Mean SD Median P-value†
HbA1c (%) 7.2 1.0 7.1 7.6 1.3 7.4 7.1 0.8 7.0 0.0293
Age at the examination (years) 26.3 9.0 23.0 26.8 9.1 24.0 26.3 9.0 23.0 0.6320
T1DM diagnosis age (years) 13.0 7.6 11.2 13.3 8.5 11.5 12.9 7.4 12.0 0.8490
Diabetes duration (years) 13.4 7.4 13.0 13.5 7.1 14.0 13.5 7.5 13.0 0.7265
Time on CSII (years) 4.8 3.5 4.5 5.0 3.3 5.5 4.8 3.6 4.5 0.5035
BMI (kg/m2) 23.3 3.1 23.0 23.0 2.9 22.1 23.4 3.1 23.2 0.2519
Glycemia from glucose meter (mg/dL) 148.4 27.4 146.7 156.3 32.2 153.1 144.8 24.2 143.3 0.0491
No. blood glucose measurements per day (n) 6.4 3.0 5.7 6.5 2.8 6.2 6.4 3.1 5.7 0.7362
Daily insulin dose (IU) 46.6 14.1 44.5 45.8 13.6 43.6 46.8 14.3 44.8 0.7130
Daily insulin dose per kg of body mass (IU/kg) 0.69 0.16 0.70 0.68 0.19 0.68 0.69 0.15 0.70 0.9072
No. hypoglycemic episodes per 100
blood glucose measure (n)
5.3 5.4 4.0 5.1 7.6 2.6 5.4 4.4 4.3 0.0506
Sleep duration (h) 7.2 1.1 7.0 5.8 0.4 6.0 7.7 0.7 8.0 0.0000
BMI, body mass index, CSII, continuous subcutaneous insulin infusion; HbA1c, glycated hemoglobin; SD, standard deviation; T1DM, type 1 diabetes
mellitus. †P-value for the comparison between short sleep duration group vs long sleep duration group is shown. ‡Retinopathy was diagnosed
based on ophthalmological examination. §Neuropathy was defined as the presence of its clinical signs or symptoms during physical examination.
¶Nephropathy was diagnosed based on urinary albumin excretion above 30 mg/day or glomerular filtration rate <60 mL/min/1.73 m2.
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noted that both examined behaviors were not predictors of
reaching glycemic goals, as defined by the HbA1c levels,
although this could be at least partially attributed to the low
power of the analysis.
The present report also had several additional limitations. It
was a retrospective study; therefore, causality could not be
identified, and the cumulative effect of temporal change in
sleep duration could not be evaluated. Sleep duration was self-
reported, thus, recall error might exist. The impact of potential
confounders should also be mentioned. For example, we did
not collect information about the nature of the patients’
employment or the presence of possible concomitant condi-
tions, such as obstructive sleep apnea. Thus, we cannot
entirely exclude the contribution of these or other confound-
ing factors to the study results. Additionally, the choice of
cut-off points should perhaps be discussed. We have chosen
6 h to differentiate between short and long sleep duration
based on previously published papers14,15. We have tried to
stay consistent with these earlier reports. We also arbitrarily
set the threshold for late eating to 22.00 h, as this complies
with our common clinical practice in which we actively dis-
courage patients to consume food after this time (unless justi-
fied by low glucose value). Finally, we have to acknowledge
that the questionnaire used in the present research was not
validated.
To conclude, we have found that shorter sleep duration, but
not late-night snacking, was associated with poorer glycemic
control in adult type 1 diabetic patients treated with CSII. It is
advised in clinical practice that patients follow the recom-
mended rules of sleep hygiene. Further research is required,
especially in the assessment of the efficacy of lifestyle interven-
tions on the course of type 1 diabetes.
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